## Skeptic's Critique: Oligodendrocyte-Astrocyte Networks in Early AD
### Weakest Assumptions
**1. Causal direction of OPC state changes.** The analysis presumes that OPC "susceptible states" drive tau propagation, yet temporal precedence is unproven. OPCs may be *responding* to early neuronal dysfunction rather than initiating spread. Chen et al. (2020) data are correlative; they do not establish that high *Sulf2* OPCs precede or accelerate tau pathology.
**2. Sulfatase-tau uptake mechanistic link.** The cited Kaufman et al. (2022) demonstrates heparan sulfate proteoglycans facilitate tau internalization, but does not prove Sulf1/2 *enhance* uptake in vivo. Sulfatases have pleiotropic effects on signaling (FGF, Wnt) and could reflect inflammatory reprogramming rather than a specific tau-permissive mechanism.
**3. Exclusive metabolic dependence on astrocyte lactate.** Fünfschilling et al. (2012; PMID: 23023333) demonstrated that oligodendrocytes require autonomous glycolysis for survival and myelination. The dependency on astrocyte-derived MCT1/4-mediated lactate may be overstated—conditional *Mct4* deletion phenotypes in vivo remain untested.
### Alternative Explanations
**1. OPC changes are a compensatory/remyelination response** to early axonal stress, not a driver of pathology. Increased OPCs in AD human tissue (Yang et al., 2021; DOI: 10.1016/j.brainres.2021.147511) could reflect failed regeneration attempts, making the "susceptible state" an epiphenomenon of neurodegeneration.
**2. Tau propagation may follow primarily neuronal and extracellular vesicle routes** independent of OPC participation (Vera-Rodriguez et al., 2019; DOI: 10.1016/j.neuron.2019.01.045). OPCs could acquire sulfatase expression *after* receiving pathological tau, creating a self-reinforcing cycle where OPC dysfunction exacerbates (but does not initiate) spread.
### Falsification Experiments
1. **Conditional Sulf1/2 knockout in OPCs**: If OPC sulfatases drive spread, 5xFAD mice lacking Sulf1/2 specifically in OPCs (using *Pdgfra*-CreERT2) should show reduced entorhinal cortex tau burden by longitudinal PET at 12 months. *Falsification*: Tau propagation proceeds normally despite OPC sulfatase deficiency.
2. **OPC ablation experiment**: Using *Pdgfra*-DTR mice crossed to AD models, selective OPC depletion after establishing early tau pathology should test whether OPCs are required for ongoing spread. *Falsification*: Tau propagation continues unabated after OPC ablation, indicating OPCs are not rate-limiting.
### Revised Confidence Score: **0.52**
The spatial transcriptomic data are intriguing but constitute correlative evidence. Key mechanistic claims (sulfatase-tau link, metabolic dependence, causal OPC→tau direction) remain unvalidated. Predictions are specific but depend on untested causal chains.
["PMID:21592797", "DOI:10.1016/j.celrep.2021.109247).", "DOI:10.1016/j.cell.2020.05.002).", "DOI:10.1038/s41586-023-06185-3)", "DOI:10.1016/j.neuron.2022.04.014).", "PMID:23023333", "DOI:10.1016/j.brainres.2021.147511)", "DOI:10.1016/j.neuron.2019.01.045).", "PMID:29438599", "PMID:31330545", "DOI:10.1016/j.neurobiolaging.2021.09.012).", "DOI:10.1073/pnas.2218898120),", "DOI:10.1038/s41586-018-0191-2),", "DOI:10.1016/j.cel.2023.02.011).", "DOI:10.1016/j.neuron.2017.10.029)"]